Application
Immunohistochemistry demonstrating detection of ELOVL6 in human brain tissue. Primary antibody was used at a concentration of 5.0 µg/mL.Application
Western blot analysis showing detection of ELOVL6 in human brain tissue lysate with primary antibody at 1.0 µg/mL (lane A) and 2.0 µg/ml. (lane B).| Product Name | Elovl6 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to Elovl6Lipogenesis is a key event in the energy storage system and is controlled by the transcription factor sterol regulatory element-binding protein (SREBP)-1. Elongation of very long chain fatty acids protein 6 (ELOVL6) is a member of fatty acyl-CoA elongase gene family that converts palmitic to stearic acid and it has been shown to be a target of SREBP-1, playing an important role in de novo synthesis of long-chain saturated and monosaturated fatty acids in conjunction with fatty acid synthase and stearoyl-CoA desaturase. ELOVL6 was predicted to be important for tissue fatty acid composition. Recent studies suggest that inhibition of this elongase could be a new therapeutic approach for ameliorating insulin resistance, diabetes and cardiovascular risks, even in the presence of a continuing state of obesity. |
| Immunogen | ELOVL6 Antibody was produced from whole rabbit serum prepared by repeated immunizations with a peptide near the n-terminus of the human ELOVL6. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ELISAIHCWB |
| *Optimal dilutions/concentrations should be determined by the researcher. | |
| Species Reactivity | HumanMouseRatBovine |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | FAE , LCE , FACE , ELOVL6 |
|---|---|
| Target | Elovl6 |
Application
Immunohistochemistry demonstrating detection of ELOVL6 in human brain tissue. Primary antibody was used at a concentration of 5.0 µg/mL.
Application
Western blot analysis showing detection of ELOVL6 in human brain tissue lysate with primary antibody at 1.0 µg/mL (lane A) and 2.0 µg/ml. (lane B).| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. |
| Storage Buffer | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 and 0.01% (w/v) Sodium Azide |
